This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chemours (CC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Chemours (CC) Q4 Earnings Beat Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 10% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Chemours (CC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours and PCC Group Enter Into Chlorine Supply Agreement
by Zacks Equity Research
CC takes a critical step further in its Pathway to Thrive operational excellence transformation by partnering with the PCC Group
Why Is Albemarle (ALB) Up 1.2% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DuPont de Nemours (DD) Down 2.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemours (CC) Up 8.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sociedad Quimica's Earnings and Revenues Miss Estimates in Q3
by Zacks Equity Research
SQM sees volume growth in almost all of its business lines amid headwinds from weaker year-over-year pricing in Q3.
Valvoline's Earnings and Revenues Surpass Estimates in Q4, Up Y/Y
by Zacks Equity Research
VVV's fiscal fourth-quarter earnings and sales top estimates on higher system-wide same-store sales.
Flexible Solutions Earnings Miss Estimates in Q3, Revenues Up Y/Y
by Zacks Equity Research
FSI sees higher sales in Q3 on increased customer orders and expects a strong upside in profits for both existing and new businesses in 2025.
ICL Group's Earnings and Revenues Surpass Estimates in Q3
by Zacks Equity Research
ICL sees lower sales in the Potash segment in the third quarter due to lower prices and volumes.
L.B. Foster's Earnings Surpass Estimates, Revenues Miss in Q3
by Zacks Equity Research
Sustained commercial weakness in the domestic rail market unfavorably affects sales and margins in FSTR's Rail Products business in Q3.
Koppers Earnings Trounce Estimates, Revenues Fall Short in Q3
by Zacks Equity Research
KOP's Railroad and Utility Products and Services segment delivers record sales on higher pricing in Q3.
Ashland's Earnings Miss in Q4, Revenues Surpass Estimates
by Zacks Equity Research
ASH sees higher sales volumes in Personal Care, Specialty Additives and Intermediates segments in Q4.
Westlake's Q3 Earnings and Revenues Miss Estimates on Lower Volumes
by Zacks Equity Research
WLK sees lower sequential sales in Q3 as lower sales volume more than offset an increase in average sales prices.
Methanex's Earnings and Revenues Surpass Estimates in Q3
by Zacks Equity Research
MEOH benefits from a higher average realized price for methanol in Q3.
Huntsman's Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
HUN's Q3 Polyurethanes sales increase is primarily driven by rising sales volumes, partly offset by reduced MDI prices.
Albemarle's Q3 Earnings and Sales Miss on Lower Lithium Pricing
by Zacks Equity Research
Lower lithium market prices weigh on ALB's Q3 results, partly masked by volume growth and cost and productivity benefits.
Air Products' Q4 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
The flat Q4 sales of APD are attributed to 1% increased volumes and pricing offset by 2% lower energy cost pass-through.
Cabot's Q4 Earnings and Revenues Miss Estimates, Rise Y/Y
by Zacks Equity Research
The decline in Q4 EBIT of CBT's Reinforcement Material segment is due to reduced volumes in the Americas, a less advantageous regional mix and higher costs.
Kronos Worldwide's Earnings Surpass Estimates in Q3, Sales Lag
by Zacks Equity Research
Higher sales volumes as a result of stronger demand for TiO2 in all major markets drive of KRO's top line in Q3.
Chemours' Earnings and Revenues Surpass Estimates in Q3
by Zacks Equity Research
CC sees record Q3 sales in the Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.
Company News for Nov 5, 2024
by Zacks Equity Research
Companies in The News Are: CC,MAR,BAM,YUMC
Chemours (CC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.